Skip to main content

Table 2 Distribution of underlying factors in individuals with single or recurrent episodes of erysipelas

From: Recurrent erysipelas - risk factors and clinical presentation

  Single episode Recurrent episodes Odds ratio (95% CI) p-value
  n = 360 (100%) n = 142 (100%)   
Age, years (95% CI) 58.0 (56.1-60.0) 61.5 (58.6-64.1) 1.1 (1.0-1.2) 0.05
Gender, % male 211 (58.6) 75 (52.8) 0.8 (0.5-1.2) 0.36
Local operation 71 (19.7) 46 (32.4) 2.0 (1.3-3.0) <0.01
CABG1) 16 (4.4) 13 (9.2) 2.2 (1.0-4.6) 0.05
Localization     
Lower limbs 231 (64.2) 111 (78.2) 1 (reference) <0.01
Upper limbs 60 (16.7) 15 (10.6) 0.5 (0.3-0.9)  
Thorax/trunc 24 (6.7) 11 (7.6) 0.9 (0.4-2.0)  
Head/face 45 (12.5) 6 (3.5) 0.3 (0.1-0.7)  
Skin disease 42 (11.7) 24 (16.9) 1.5 (0.9-2.6) 0.12
Malignancy 53 (14.7) 36 (25.4) 2.0 (1.2-3.7) <0.01
Radiation therapy 17 (4.7) 11 (7.8) 1.7 (0.8-3.7) 0.19
Immuno-suppressive therapy 36 (14.1) 8 (8.2) 0.5 (0.2-1.2) 0.14
Arterial insufficiency 13 (3.6) 8 (5.6) 1.6 (0.6-3.9) 0.32
Venous insufficiency1) 16 (4.4) 16 (11.3) 2.7 (1.3-5.6) <0.01
Lymphedema 8 (2.2) 19 (13.4) 6.8 (2.9-15.9) <0.01
Diabetes mellitus 52 (14.4) 25 (17.6) 1.3 (0.8-2.1) 0.38
Polyneuropathy 11 (3.1) 4 (2.8) 0.9 (0.3-2.9) 0.89
Vascular disease 62 (17.2) 24 (16.9) 1.0 (0.6-1.6) 0.93
COPD 22 (6.1) 3 (2.1) 0.3 (0.1-1.1) 0.09
Systemic inflammatory disease 16 (4.5) 4 (2.8) 0.6 (0.2-1.8) 0.41
Wound 176 (49.0) 53 (37.3) 0.6 (0.4-0.9) 0.02
Toe web intertrigo1) 10 (2.8) 8 (5.6) 2.1 (0.8-5.4). 0.13
Severe obesitas 1 (0.3) 4 (2.8) 10.4 (1.2-93.9) 0.04
Liver disease 9 (2.5) 4 (2.8) 1.1 (0.3-3.7) 0.84
  1. 1)-Calculated in the 342 individuals with erysipelas in the lower limbs, 229 and 113 respectively.